1. Home
  2. CRNT vs KPTI Comparison

CRNT vs KPTI Comparison

Compare CRNT & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ceragon Networks Ltd.

CRNT

Ceragon Networks Ltd.

HOLD

Current Price

$2.66

Market Cap

228.1M

Sector

Technology

ML Signal

HOLD

Logo Karyopharm Therapeutics Inc.

KPTI

Karyopharm Therapeutics Inc.

HOLD

Current Price

$8.13

Market Cap

194.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRNT
KPTI
Founded
1996
2008
Country
Israel
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
228.1M
194.8M
IPO Year
2000
2013

Fundamental Metrics

Financial Performance
Metric
CRNT
KPTI
Price
$2.66
$8.13
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
7
Target Price
$3.50
$16.00
AVG Volume (30 Days)
539.1K
420.7K
Earning Date
05-19-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$146,067,000.00
Revenue This Year
$9.11
N/A
Revenue Next Year
$6.70
$22.36
P/E Ratio
N/A
N/A
Revenue Growth
N/A
0.57
52 Week Low
$1.82
$3.65
52 Week High
$2.84
$10.99

Technical Indicators

Market Signals
Indicator
CRNT
KPTI
Relative Strength Index (RSI) 57.47 47.78
Support Level $2.30 $5.43
Resistance Level $2.82 $9.32
Average True Range (ATR) 0.15 0.71
MACD -0.01 -0.13
Stochastic Oscillator 65.52 36.84

Price Performance

Historical Comparison
CRNT
KPTI

About CRNT Ceragon Networks Ltd.

Ceragon Networks Ltd is a wireless transport specialist, providing wireless connectivity solutions to markets globally across various industries, including wireless (mobile) network service providers and private networks, enabling them to build new networks and evolve networks towards 4G and 5G services. Its portfolio mainly comprises the IP-20 and IP-50 product series, including integrated multi-technology radio units operating across frequencies from 4 GHz to 86 GHz, as well as single-radio devices used for wireless data transport. Additionally, the company offers turnkey services including: network and radio planning, site survey, installation, network auditing and optimization, and more. Geographically, it derives maximum revenue from India, followed by North America and other regions.

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).

Share on Social Networks: